AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 1 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,126,000 | +125.2% | 32,688 | +9.2% | 0.59% | +149.4% |
Q2 2020 | $500,000 | +84.5% | 29,935 | +59.2% | 0.24% | +111.6% |
Q1 2020 | $271,000 | -60.3% | 18,800 | -7.8% | 0.11% | +0.9% |
Q4 2019 | $682,000 | +157.4% | 20,386 | +61.4% | 0.11% | +109.4% |
Q3 2019 | $265,000 | -4.7% | 12,634 | -5.3% | 0.05% | -10.2% |
Q2 2019 | $278,000 | +3.7% | 13,338 | +11.2% | 0.06% | -89.6% |
Q1 2019 | $268,000 | -18.0% | 11,993 | -12.4% | 0.57% | +917.9% |
Q4 2018 | $327,000 | -24.7% | 13,687 | -13.9% | 0.06% | +24.4% |
Q3 2018 | $434,000 | -40.8% | 15,893 | -41.7% | 0.04% | -93.1% |
Q2 2018 | $733,000 | +4.3% | 27,252 | +23.3% | 0.65% | +6.2% |
Q1 2018 | $703,000 | +79.8% | 22,101 | +113.8% | 0.61% | +24.2% |
Q4 2017 | $391,000 | -11.9% | 10,336 | -42.3% | 0.49% | +718.3% |
Q3 2017 | $444,000 | +32.9% | 17,898 | +10.1% | 0.06% | +20.0% |
Q2 2017 | $334,000 | +23.2% | 16,261 | +30.4% | 0.05% | +4.2% |
Q1 2017 | $271,000 | +17.3% | 12,472 | +10.6% | 0.05% | -30.4% |
Q4 2016 | $231,000 | -21.2% | 11,276 | -42.2% | 0.07% | -51.4% |
Q3 2016 | $293,000 | +38.9% | 19,501 | 0.0% | 0.14% | -9.6% |
Q2 2016 | $211,000 | +14.1% | 19,501 | +42.7% | 0.16% | -38.4% |
Q1 2016 | $185,000 | – | 13,666 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |